Home » Topics » Hematologic, BioWorld Science

Hematologic, BioWorld Science
RSS

Principia Biopharma reports preliminary data from phase I/II trial of PRN-1008 in ITP

Oct. 16, 2019

Heterozygous mouse model of VWD associated with dominant-negative mutations

Oct. 11, 2019

FDA approves Wilate for hemophilia A

Oct. 9, 2019

Discovery of novel potent fully human FVIII mimetic BiAb, KY-1049

Oct. 9, 2019

BARDA contract supports Platelet BioGenesis' development of donor-independent platelets

Oct. 8, 2019

Phase I study of CSL-200 gene therapy in adults with severe sickle cell disease

Oct. 3, 2019

Neurotransmitter receptor stimulates early blood cell progenitors

Oct. 2, 2019

Japanese approval for Evrenzo for anemia associated with chronic kidney disease in dialysis patients

Sep. 20, 2019

Inflammation stress induces red blood cell formation

Sep. 18, 2019

Edoxaban in atrial fibrillation patients after PCI: Results from ENTRUST-AF PCI

Sep. 17, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...